Pharmacoeconomic analysis of modern oral hypoglycemic agents with inadequate glycemic control on metformin

Pharmacoeconomic analysis of modern oral hypoglycemic agents with inadequate glycemic control on metformin

The aim. Based on a pharmacoeconomic analysis (PHe) of the use of sodium-glucose cotransporter-2 inhibitors (iSGLT2) and dipeptidyl peptidase-4 (iDPP-4) inhibitors to determine the optimal treatment strategy in patients with type 2 diabetes mellitus (T2DM) with inadequate glycemic control in metform...

Full description

Bibliographic Details
Main Authors: M. F. Kalashnikova, D. Yu. Belousov, A. E. Cheberda, V. V. Fadeev
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2019-08-01
Series:Качественная клиническая практика
Subjects:
type 2 diabetes mellitus
cost-eff ectiveness analysis
dapaglifl ozin
canaglifl ozin
empaglifl ozin
alogliptin
sitagliptin
saxagliptin
add-on metformin
vildagliptin
linagliptin
lyg
qaly
Online Access:https://www.clinvest.ru/jour/article/view/437

Internet

https://www.clinvest.ru/jour/article/view/437

Similar Items